Revance Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	198,160	178,549	228,459	122,286	174,680	239,098	Upgrade
Market Cap Growth	-21.85%	-21.85%	86.82%	-29.99%	-26.94%	446.19%	Upgrade
Last Close Price	789.00	704.00	836.48	436.35	580.26	806.17	Upgrade
PE Ratio	-	-	7.30	36.05	13.42	16.66	Upgrade
PS Ratio	2.83	2.55	3.74	1.60	2.01	3.14	Upgrade
PB Ratio	1.57	1.41	1.72	1.21	1.65	2.64	Upgrade
P/FCF Ratio	16.00	14.42	31.74	-	3.42	-	Upgrade
P/OCF Ratio	14.90	13.43	28.36	-	3.38	-	Upgrade
Debt / Equity Ratio	0.69	0.69	0.75	4.13	3.98	4.01	Upgrade
Debt / FCF Ratio	7.03	7.03	13.92	-	8.26	-	Upgrade
Asset Turnover	0.10	0.10	0.05	0.05	0.06	0.06	Upgrade
Quick Ratio	0.90	0.90	0.96	0.96	0.96	0.94	Upgrade
Current Ratio	1.14	1.14	1.15	1.04	1.07	1.06	Upgrade
Return on Equity (ROE)	-6.18%	-6.18%	14.68%	3.21%	13.26%	17.17%	Upgrade
Return on Assets (ROA)	-1.09%	-1.09%	1.52%	0.21%	0.87%	1.19%	Upgrade
Earnings Yield	-2.56%	-2.84%	13.70%	2.77%	7.45%	6.00%	Upgrade
FCF Yield	6.25%	6.94%	3.15%	-26.06%	29.23%	-24.39%	Upgrade
Dividend Yield	3.81%	4.30%	2.75%	3.60%	2.64%	1.49%	Upgrade
Payout Ratio	-	-	13.04%	121.76%	29.84%	13.76%	Upgrade
Buyback Yield / Dilution	0.46%	0.46%	2.58%	-1.40%	-1.25%	1.00%	Upgrade
Total Shareholder Return	4.40%	4.76%	5.33%	2.20%	1.39%	2.49%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.